|Day Low/High||8,32 / 8,46|
|52 Wk Low/High||13,39 / 29,61|
Karyopharm Therapeutics and Gamida Cell are promising companies that have seen their shares pull back significantly in recent weeks.
Biotechnology is always high risk but the right plays move unlike anything else.
It is good to be sitting in for Doug Kass on the Daily Diary this Friday. Hopefully we can end the trading week on an up note. It has been a relatively good week for investors, despite a spike in coronavirus cases in China the other day that had equ...
Karyopharm Therapeutics and Pieris Pharmaceuticals are climbing this week on positive news, while Supernus Pharmaceuticals takes a hit.
Intra-Cellular Therapies and Acadia Pharmaceuticals are worth investors' attention.
As Kenny Rogers sang, you've got to know when to hold 'em and know when to fold 'em… and sometimes when not to play a hand at all.
Markets continue to be down across the board as we approach mid-day. Financials are taking it on the chin as trade tensions escalate with China. The financial sector is down 1% on the day but have improved a tad from earlier levels. Despite all the ...
Even concerns about a possible Fed rate hike do not appear to be affecting traders.